All articles by Aninda Chakraborty
Aninda Chakraborty
UK to double troops in Estonia amid Ukraine crisis
The UK has also got 1,000 personnel ready to support humanitarian responses, if required.
Advarra launches new platform to support clinical trials
SiteIQ platform will offer insights on clinical research site experience, capacity, quality and performance among others.
Boehringer Ingelheim and Amgen collaborate on cancer trial
The trial will evaluate the combination of BI 1701963 and Lumakras (sotorasib) in patients with lung and colorectal cancers.
FDA accepts Intellia Therapeutics’ application for leukaemia study
The study will evaluate the safety, tolerability, cell kinetics and anti-tumour activity of NTLA-5001 in adults with AML.
Keen Eye introduces AI-powered platform to support clinical trials
The platform will help in accelerating clinical trials with deep learning-based image analysis.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Triall enters partnership to anchor Covid-19 data to blockchain
Triall will leverage LTO Network’s blockchain technology and infrastructure to anchor the research data.
Boehringer and Lilly report positive data from EMPEROR-Preserved trial
The trial tested the safety and efficacy of Jardiance in patients with chronic HFpEF.
Anavex reports positive data from Parkinson’s disease dementia study
ANAVEX 2-73 slowed the progression of motor and non-motor symptoms in moderately advanced patients with Parkinson’s disease.
Polyphor’s balixafortide fails in late-stage breast cancer study
The failure also prompted Polyphor to carry out a strategic assessment about the future of the company.
Idorsia starts Phase III study to assess efficacy of heart attack drug
The study plans to enrol around 14,000 patients who are at high risk of recurrent acute myocardial infarction (AMI).